OncoPrecision
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
180 Varick St Fl 6, New York City, New Y...Website
oncoprecision.bioRevenue
<$5 MillionIndustry
About OncoPrecision
OncoPrecision Org Chart
Is OncoPrecision your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if OncoPrecision has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if OncoPrecision had a recent Job posting/layoffs
Earning: See what the market has to say on OncoPrecision recently announced quarterly report
OncoPrecision, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once OncoPrecision has new funding data
Check out if OncoPrecision is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when OncoPrecision launches new products
Congratulate Masked Content for being promoted to Masked Content at OncoPrecision
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to OncoPrecision
Compare insights from companies similar to OncoPrecision, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
OncoPrecision is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
OncoPrecision is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about OncoPrecision.
OncoPrecision Tech Stack
A closer look at the technologies used by OncoPrecision
OncoPrecision News & Media
OncoPrecision Raises $3.3M Seed Funding to Improve Cancer Patient Outcomes and Drug Development Efforts with “Patient Micro Avatars”
NEW YORK--(BUSINESS WIRE)--Today OncoPrecision announces $3.3 million in Seed Funding to further develop its Patient Micro Avatar technology which seeks to recreate cancer patients’ disease ex-vivo to precisely evaluate the response of these avatars to a wide range of both Standard of Care and explorational treatments within a week. The company’s goal is to unlock precise patient-specific insights that may help oncologists determine the best course of treatment, as well as to collaborate with t
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding OncoPrecision
Founder 2020, OncoPrecision is a medical screening technologies provider, headquartered in Argentina.... Read More